The agreement gives the pharmaceutical biotechnology company Asia United (China)
Medical Co. Limited the exclusive rights to sell BioGaia's probiotic drops in
Mainland China. - This is a firm first step into the Chinese market for our
branded supplement products, says Peter Rothschild, President, BioGaia AB.
Launch of the product is estimated at the end of 2011 following relevant local
registration which will be taken care of by Asia United. The products will be
sold under the BioGaia brand. About 40 % of BioGaia's sales of finished products
are today sold under the BioGaia brand or are co-branded.
Asia United is a member of the Unilab Group, a privately held regional
pharmaceutical and healthcare company with a leading position in Southeast Asia
and with strong brands in the Philippines, Indonesia, Thailand, Malaysia,
Singapore, Vietnam and Myanmar.
Asia United primarily sells oral cholera vaccines and growth hormones. Through
27 regional offices it covers the entire country with over 300 medical sales
representatives visiting paediatricians and travel clinics. With its vast
experience of marketing and distribution of cold-chain pharmaceutical products,
Asia United is ideally suited to handle BioGaia's probiotic drops, as they
require refrigeration.
- We are very pleased to add this product to our growing business in China and
see great potential for this well-documented and innovative product in a growing
Chinese probiotics market, says Dr Lee, Director, Asia United.
- This is an important first step for us in to China and we are convinced that
Asia United is an ideal partner to help us establish our drops in a very large
and growing market, says Peter Rothschild, President, BioGaia AB.
For additional information contact:
Dr Lee, Director, Asia United, telephone +86 (21) 50 31 88 00
Peter Rothschild, President, telephone: +46 8 -555 293 00
BioGaia is a biotechnology company that develops, markets and sells probiotic
products with documented health benefits. The products are primarily based on
the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic,
health-enhancing effects. The class B share of the Parent Company BioGaia AB is
quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm.
www.biogaia.com
[HUG#1421428]
